Index by author
June 01, 2021; Volume 377,Issue 3
A
Acosta, Teeshavi
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Ali, Heba
- Open AccessTherapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. CassisJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Alsiraj, Yasir
- Open AccessTherapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. CassisJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
B
Bartkowski, Darian
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Baumann, Michael H.
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Bergman, Jack
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Berner-Hansen, Mark
- You have accessComments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam SteensbergJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Brice, Nicola L.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Burley, J. Russell
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
C
Callahan, Michael F.
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Carlton, Mark B.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Cassis, Lisa A.
- Open AccessTherapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. CassisJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Centazzo, Nicole
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Chen, Shuang
- You have accesscirc-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 AxisZhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang ChenJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Chen, Yun
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Cheng, Che-Ping
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Cheng, Heng-Jie
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Cheung, Toni
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Choi, Young Hee
- Open AccessA Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo SynergismYoung Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming YuJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Chojnacki, Michael R.
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Ciccarone, Fabio
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Clausen, Trine R.
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Concheiro, Marta
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Coop, Andrew
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
D
Dawson, Lee A.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
De Gabrieli, Antonio
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Dickson, Louise
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Ding, Li-li
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Divona, Maria Domenica
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
E
Elmore, Joshua S.
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Ensor, Mark
- Open AccessTherapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. CassisJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Euler, Adriana
- Open AccessCharacterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion TransportersMichele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin LochnerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
F
Faraoni, Isabella
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Fletcher, Madeleine M.
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Furness, Sebastian G.B.
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
G
Giansanti, Manuela
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Graziani, Grazia
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
H
Häusler, Stephanie
- Open AccessCharacterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion TransportersMichele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin LochnerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Herrington, David
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Hick, Caroline A.
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Hitchcock, Stephen H.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Höhn, Vera
- Open AccessCharacterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion TransportersMichele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin LochnerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Hosea, Natalie
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Hou, Zehui
- You have accesscirc-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 AxisZhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang ChenJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
J
Jiang, Lin-shan
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Jiang, Zhipeng
- You have accesscirc-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 AxisZhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang ChenJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Johnson, Chad R.
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Ju, Zheng-cai
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Jusko, William J.
- You have accessSynergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and ProliferationQingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. StraubingerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Jutkiewicz, Emily M.
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
K
Kangas, Brian D.
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Kanta, Anne
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Karimi, Terry
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Kaushal, Nidhi
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Keov, Peter
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Kitzman, Dalane
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Kruse, Thomas
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
L
Larsen, Bjarne Due
- You have accessComments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam SteensbergJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Lawrence, Jason
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Leuenberger, Michele
- Open AccessCharacterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion TransportersMichele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin LochnerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Li, Tiankai
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Li, Wei
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Liang, Ching Ling
- Open AccessTherapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. CassisJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Liang, Zhiqiang
- You have accesscirc-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 AxisZhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang ChenJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Lin, Qingxiang
- You have accessSynergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and ProliferationQingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. StraubingerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Liu, Wei
- You have accesscirc-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 AxisZhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang ChenJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Liu, Yixi
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Liu, Zhenzhen
- Open AccessA Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo SynergismYoung Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming YuJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Lochner, Martin
- Open AccessCharacterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion TransportersMichele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin LochnerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
M
Ma, Wen Wee
- You have accessSynergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and ProliferationQingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. StraubingerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Mager, Donald E.
- You have accessSynergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and ProliferationQingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. StraubingerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Mennen, Grace
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Monenschein, Holger
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Mulligan, Victoria J.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Murphy, Sean T.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
O
Ottone, Tiziana
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
P
Page, Keith
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Powell, Justin
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Prete, Salvatore Pasquale
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
Q
Qian, Zhicheng
- You have accessSynergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and ProliferationQingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. StraubingerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
R
Rice, Kenner C.
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Rodriguez, Raider
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
Russo, Joseph
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
S
Schiffer, Hans H.
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Sexton, Patrick M.
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Shao, Qun
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Sheardown, Steve
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Skarbaliene, Jolanta
- You have accessComments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam SteensbergJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Steensberg, Adam
- You have accessComments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”Jolanta Skarbaliene, Bjarne Due Larsen, Mark Berner-Hansen and Adam SteensbergJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 369; DOI: https://doi.org/10.1124/jpet.120.000426
Stieger, Bruno
- Open AccessCharacterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion TransportersMichele Leuenberger, Stephanie Häusler, Vera Höhn, Adriana Euler, Bruno Stieger and Martin LochnerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 346-357; DOI: https://doi.org/10.1124/jpet.120.000449
Straubinger, Robert M.
- You have accessSynergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and ProliferationQingxiang Lin, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma and Robert M. StraubingerJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 370-384; DOI: https://doi.org/10.1124/jpet.120.000412
Sun, Huikai
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Sun, Shuai
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Suzuki, Masaki
- You have accessBrain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic EffectsNicole Centazzo, Michael R. Chojnacki, Joshua S. Elmore, Raider Rodriguez, Teeshavi Acosta, Masaki Suzuki, Kenner C. Rice, Michael H. Baumann and Marta ConcheiroJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 398-406; DOI: https://doi.org/10.1124/jpet.121.000531
T
Thatcher, Sean E.
- Open AccessTherapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II–Induced Atherosclerosis, Abdominal Aortic Aneurysms, and HypertensionYasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor and Lisa A. CassisJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 326-335; DOI: https://doi.org/10.1124/jpet.121.000525
Truong, Tin T.
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Tu, Mei-Juan
- Open AccessA Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo SynergismYoung Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming YuJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
V
Voso, Maria Teresa
- You have accessPoly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin CManuela Giansanti, Antonio De Gabrieli, Salvatore Pasquale Prete, Tiziana Ottone, Maria Domenica Divona, Terry Karimi, Fabio Ciccarone, Maria Teresa Voso, Grazia Graziani and Isabella FaraoniJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 385-397; DOI: https://doi.org/10.1124/jpet.121.000537
W
Wang, Zheng-tao
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Winger, Gail
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Woods, James H.
- You have accessNovel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on CognitionChad R. Johnson, Brian D. Kangas, Emily M. Jutkiewicz, Gail Winger, Jack Bergman, Andrew Coop and James H. WoodsJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 336-345; DOI: https://doi.org/10.1124/jpet.120.000337
Wootten, Denise
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
X
Xu, Xiao
- You have accessDevelopment of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson DiseaseNicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock and Mark B. CarltonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 407-416; DOI: https://doi.org/10.1124/jpet.120.000438
Y
Yang, Li
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Yu, Ai-Ming
- Open AccessA Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo SynergismYoung Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming YuJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Yu, Ai-Xi
- Open AccessA Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo SynergismYoung Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming YuJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Yu, Jie-jing
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
Yu, Zhuomin
- You have accesscirc-Keratin 6c Promotes Malignant Progression and Immune Evasion of Colorectal Cancer through microRNA-485-3p/Programmed Cell Death Receptor Ligand 1 AxisZhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang Liang and Shuang ChenJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 358-367; DOI: https://doi.org/10.1124/jpet.121.000518
Z
Zhang, Chao
- Open AccessA Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo SynergismYoung Hee Choi, Chao Zhang, Zhenzhen Liu, Mei-Juan Tu, Ai-Xi Yu and Ai-Ming YuJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 305-315; DOI: https://doi.org/10.1124/jpet.121.000584
Zhang, Xiaowei
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Zhao, David
- You have accessChronic Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart FailureYixi Liu, Qun Shao, Heng-Jie Cheng, Tiankai Li, Xiaowei Zhang, Michael F. Callahan, David Herrington, Dalane Kitzman, David Zhao and Che-Ping ChengJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 316-325; DOI: https://doi.org/10.1124/jpet.120.000361
Zhao, Peishen
- Open AccessAM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective AgonistsMadeleine M. Fletcher, Peter Keov, Tin T. Truong, Grace Mennen, Caroline A. Hick, Peishen Zhao, Sebastian G.B. Furness, Thomas Kruse, Trine R. Clausen, Denise Wootten and Patrick M. SextonJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 417-440; DOI: https://doi.org/10.1124/jpet.121.000567
Zhuang, Tong-xi
- You have accessGinsenoside Ro Ameliorates High-Fat Diet–Induced Obesity and Insulin Resistance in Mice via Activation of the G Protein–Coupled Bile Acid Receptor 5 PathwayLin-shan Jiang, Wei Li, Tong-xi Zhuang, Jie-jing Yu, Shuai Sun, Zheng-cai Ju, Zheng-tao Wang, Li-li Ding and Li YangJournal of Pharmacology and Experimental Therapeutics June 2021, 377 (3) 441-451; DOI: https://doi.org/10.1124/jpet.120.000435
In this issue
Advertisement